Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group. [electronic resource]
Producer: 19970224Description: 1194-9 p. digitalISSN:- 0149-5992
- Blood Glucose -- metabolism
- C-Peptide -- blood
- Diabetes Mellitus, Type 2 -- blood
- Double-Blind Method
- Drug Administration Schedule
- Female
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemic Agents -- adverse effects
- Insulin -- blood
- Male
- Middle Aged
- Postprandial Period
- Sulfonylurea Compounds -- adverse effects
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.